55 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday.
RBC Capital Maintains Outperform on Magnite, Lowers Price Target to $36
RBC Capital maintains Magnite (NASDAQ:MGNI) with a Outperform and lowers the price target from $40 to $36.
24 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday.
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Vertical Research Downgrades Magnite to Negative
Vertical Research downgrades Magnite (NASDAQ:MGNI) from Positive to Negative.
Magnite Granted U.S. Patent Titled ‘Platform for programmatic advertising’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=2887&f=G&l=50&d=PTXT&p=58&S1=20210914&OS=20210914&RS=20210914